KMB
39
2
VRSN
53
-4
DTE
56
2
UA
50
-9
VFC
53
5
F
58
11
FITB
63
3
LMT
34
2
HOG
35
2
MRK
25
-2
MCHP
41
4
CMA
61
5
RL
72
4
CFG
70
6
ADT
53
3
URBN
56
14
SNA
68
-2
DOW
44
10
HD
57
2
HRB
57
5
KMB
39
2
VRSN
53
-4
DTE
56
2
UA
50
-9
VFC
53
5
F
58
11
FITB
63
3
LMT
34
2
HOG
35
2
MRK
25
-2
MCHP
41
4
CMA
61
5
RL
72
4
CFG
70
6
ADT
53
3
URBN
56
14
SNA
68
-2
DOW
44
10
HD
57
2
HRB
57
5
Financhill
Back

Regenxbio Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
26

RGNX
Regenxbio

Last Price:
9.60
Seasonality Move:
-5.7%
Sell
33

SRPT
Sarepta Therapeutics

Last Price:
114.28
Seasonality Move:
16.38%
Sell
26
Regenxbio (RGNX) is a Sell

Is Regenxbio a Buy, Sell or Hold?

  • The current Regenxbio [RGNX] share price is $9.59. The Score for RGNX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • RGNX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $114.23. The Score for SRPT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RGNX Stock Price Chart

What is Regenxbio's stock price today?

  • The Regenxbio share price today is $9.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGNX is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $114.23
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

RGNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 46.66 Sell
Chaikin Money Flow: 300118 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.94 - 10.6) Sell
Bollinger Bands (100): (9.84 - 12.8) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.42 Sell
Relative Strength Index (14 RSI): 44.35 Sell
Chaikin Money Flow: 638386 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.48 - 129.26) Sell
Bollinger Bands (100): (119.5 - 143.18) Sell

RGNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.95 Sell
20-day SMA: 9.79 Sell
50-day SMA: 10.29 Sell
200-day SMA: 14.24 Sell
8-day EMA: 9.79 Sell
20-day EMA: 9.92 Sell
50-day EMA: 10.36 Sell
200-day EMA: 13.18 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 109.13 Buy
20-day SMA: 118.03 Sell
50-day SMA: 122 Sell
200-day SMA: 130.03 Sell
8-day EMA: 111.53 Buy
20-day EMA: 115.85 Sell
50-day EMA: 121.84 Sell
200-day EMA: 126.04 Sell

Regenxbio Earnings Growth & RGNX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $3.97 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.72 per share.

Regenxbio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):